PLLWF.US Polarean Imaging plc

Healthcare Health Care Equipment & Supplies USA Stocks
0.0066 USD
Close of Aug 3, 2026
0.0010 0.0067
Market cap
USD 7.97M
P/E
-
P/B
1.09x
ROE
-271.5%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2025.

Is PLLWF.US undervalued?

Graham number

The Graham number of Polarean Imaging plc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Polarean Imaging plc fundamental analysis

No fundamental analysis for Polarean Imaging plc yet.

Polarean Imaging plc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Polarean Imaging plc

Polarean Imaging plc operates as a drug-device manufacturer and service provider for noble gas hyperpolariser devices in Canada, the United Kingdom, and the United States. The company engages in the research, development, and commercialization of novel imaging solutions with a non-invasive and radiation-free functional imaging platform. It also offers XENOVIEW, a hyperpolarized contrast agent indicated for use with magnetic resonance imaging (MRI) for evaluation of lung vent…

Full company profile